Month: March 2021

March-In Rights under the Bayh-Dole Act: Will the Pharmaceutical Industry be Victorious in Obtaining an Express Limitation to Prevent Price Control?

On December 12, 1980, the Bayh-Dole Act was enacted to provide incentives to innovate and promote the commercialization of federally funded inventions and amended the existing patent laws. In December 2002, The Economist published an opinion piece calling the Bayh-Dole Act “innovation’s golden goose” and stating that it was “[p]ossibly the most inspired piece of … Continued